检索结果 - Ronald D. Perrone

Refine Results
  1. 1
    Extrarenal manifestations of ADPKD

    Extrarenal manifestations of ADPKD 由 Ronald D. Perrone

    出版 1997
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Vascular complications in autosomal dominant polycystic kidney disease

    Vascular complications in autosomal dominant polycystic kidney disease 由 Ronald D. Perrone, Adel M. Malek, Terry Watnick

    出版 2015
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Low-Osmolar Diet and Adjusted Water Intake for Vasopressin Reduction in Autosomal Dominant Polycystic Kidney Disease: A Pilot Randomized Controlled Trial

    Low-Osmolar Diet and Adjusted Water Intake for Vasopressin Reduction in Autosomal Dominant Polycystic Kidney Disease: A Pilot Randomized Controlled Trial 由 Osama W. Amro, Jessica K. Paulus, Farzad Noubary, Ronald D. Perrone

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Tissue-Engineered Three-Dimensional<i>In Vitro</i>Models for Normal and Diseased Kidney

    Tissue-Engineered Three-Dimensional<i>In Vitro</i>Models for Normal and Diseased Kidney 由 Balajikarthick Subramanian, D. Rudym, Chris Cannizzaro, Ronald D. Perrone, Jing Zhou, David L. Kaplan

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease

    Total Kidney Volume as a Biomarker of Disease Progression in Autosomal Dominant Polycystic Kidney Disease 由 Navdeep Tangri, Ingrid Hougen, Ahsan Alam, Ronald D. Perrone, Phil McFarlane, York Pei

    出版 2017
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Inflammation, Oxidative Stress, and Insulin Resistance in Polycystic Kidney Disease

    Inflammation, Oxidative Stress, and Insulin Resistance in Polycystic Kidney Disease 由 Vandana Menon, D. Rudym, Priya Chandra, Dana C. Miskulin, Ronald D. Perrone, Mark J. Sarnak

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease

    A Randomized Clinical Trial of Metformin to Treat Autosomal Dominant Polycystic Kidney Disease 由 Stephen L. Seliger, Kaleab Z. Abebe, Kenneth R. Hallows, Dana C. Miskulin, Ronald D. Perrone, Terry Watnick, Kyongtae T. Bae

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument

    Development of the Autosomal Dominant Polycystic Kidney Disease Impact Scale: A New Health-Related Quality-of-Life Instrument 由 Dorothee Oberdhan, Jason C. Cole, Holly B. Krasa, Rebecca Cheng, Frank S. Czerwiec, Ron D. Hays, Arlene B. Chapman, Ronald D. Perrone

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial

    Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney dise... 由 Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst, Ron T. Gansevoort, Ronald D. Perrone, Ann Dandurand, John Ouyang, Frank S. Czerwiec, Jaime D. Blais

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    Discussing Conservative Management With Older Patients With CKD: An Interview Study of Nephrologists

    Discussing Conservative Management With Older Patients With CKD: An Interview Study of Nephrologists 由 Keren Ladin, Renuka Pandya, Allison Kannam, Rohini Loke, Tira Oskoui, Ronald D. Perrone, Klemens B. Meyer, Daniel E. Weiner, John B. Wong

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Characterizing Approaches to Dialysis Decision Making with Older Adults

    Characterizing Approaches to Dialysis Decision Making with Older Adults 由 Keren Ladin, Renuka Pandya, Ronald D. Perrone, Klemens B. Meyer, Allison Kannam, Rohini Loke, Tira Oskoui, Daniel E. Weiner, John B. Wong

    出版 2018
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney disease: the TEMPO 4:4 Trial

    Multicenter, open-label, extension trial to evaluate the long-term efficacy and safety of early versus delayed treatment with tolvaptan in autosomal dominant polycystic kidney dise... 由 Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst, Ron T. Gansevoort, Ronald D. Perrone, Ann Dandurand, John Ouyang, Frank S. Czerwiec, Jaime D. Blais

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease

    The effect of angiotensin-converting-enzyme inhibitors on progression of advanced polycystic kidney disease 由 Tazeen H. Jafar, Paul C. Stark, Christopher H. Schmid, Svend Strandgaard, Anne‐Lise Kamper, Giuseppe Maschio, Gavin J. Becker, Ronald D. Perrone, Andrew S. Levey

    出版 2004
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  14. 14
    Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial

    Urine Osmolality, Response to Tolvaptan, and Outcome in Autosomal Dominant Polycystic Kidney Disease: Results from the TEMPO 3:4 Trial 由 Olivier Devuyst, Arlene B. Chapman, Ron T. Gansevoort, Eiji Higashihara, Ronald D. Perrone, Vicente E. Torres, Jaime D. Blais, Wen Zhou, John Ouyang, Frank S. Czerwiec

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

    Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease 由 Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst, Ron T. Gansevoort, Jared J. Grantham, Eiji Higashihara, Ronald D. Perrone, Holly B. Krasa, John Ouyang, Frank S. Czerwiec

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial

    Effect of Tolvaptan in Autosomal Dominant Polycystic Kidney Disease by CKD Stage: Results from the TEMPO 3:4 Trial 由 Vicente E. Torres, Eiji Higashihara, Olivier Devuyst, Arlene B. Chapman, Ronald T. Gansevoort, Jared J. Grantham, Ronald D. Perrone, John Ouyang, Jaime D. Blais, Frank S. Czerwiec

    出版 2016
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Metabolomic Alterations Associated with Cause of CKD

    Metabolomic Alterations Associated with Cause of CKD 由 Morgan E. Grams, Adrienne Tin, Casey M. Rebholz, Tariq Shafi, Anna Köttgen, Ronald D. Perrone, Mark J. Sarnak, Lesley A. Inker, Andrew S. Levey, Josef Coresh

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    Effectiveness of Tolvaptan for ADPKD in US Clinical Practice With Comparison to Historical Control Data

    Effectiveness of Tolvaptan for ADPKD in US Clinical Practice With Comparison to Historical Control Data 由 Ronald D. Perrone, Diana Garbinsky, Sasikiran Nunna, Hema K. Gandhi, Ancilla W. Fernandes, Gabriela Burgos, Abisola Olopoenia, Marc DeCongelio, Martine C. Maculaitis, Xiaolei Zhou

    出版 2025
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Performance of Creatinine-Based GFR Estimating Equations in Solid-Organ Transplant Recipients

    Performance of Creatinine-Based GFR Estimating Equations in Solid-Organ Transplant Recipients 由 Saeed K. Shaffi, Katrin Uhlig, Ronald D. Perrone, Robin Ruthazer, Andrew D. Rule, John C. Lieske, Gerjan Navis, Emilio D. Poggio, Lesley A. Inker, Andrew S. Levey

    出版 2014
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease

    Total Kidney Volume Is a Prognostic Biomarker of Renal Function Decline and Progression to End-Stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease 由 Ronald D. Perrone, Samer Mouksassi, Klaus Romero, Frank S. Czerwiec, Arlene B. Chapman, Berenice Y. Gitomer, Vicente E. Torres, Dana C. Miskulin, Steve Broadbent, Jean‐Francois Marier

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: